Literature DB >> 25873884

Supratentorial tanycytic ependymoma in an adult male: case report and review of literature.

Giselle Lopez1, Roger E McLendon2, Katherine B Peters2.   

Abstract

Ependymomas, tumors of the ependymal cells, are very rare and usually present in the pediatric population. Furthermore, there are even rarer variants of ependymomas that can include cellular, papillary, clear cell, and tanycytic subtypes. We present a case of a supratentorial tanycytic ependymoma in an adult male and review the literature in regard to this rare primary central nervous system neoplasm.

Entities:  

Keywords:  Adult; Supratentorial tanycytic ependymoma; Tanycytic ependymoma

Year:  2015        PMID: 25873884      PMCID: PMC4386143          DOI: 10.1159/000380906

Source DB:  PubMed          Journal:  Case Rep Oncol        ISSN: 1662-6575


Introduction

Ependymomas are rare forms of primary brain tumors, accounting for 3–7% of all brain tumors [1, 2]. Ependymomas, composed of neoplastic ependymal cells, are thought to arise from the ependymal cells in the ventricular system. The majority occur infratentorially in the pediatric population, while a smaller fraction occurs in adults, usually in the spinal cord [1]. Rare variants of ependymomas have been described and can include cellular, papillary, clear-cell, and tanycytic variants. Tanycytic ependymomas are particularly rare and typically occur in the spinal cord as an intramedullary mass. First described by Friede and Pollak [3] in 1978, tanycytic ependymoma represents a WHO grade II ependymoma with characterized pathology described as containing bipolar cells with absent mitosis and low-to-moderate cellularity. Here we report a case of a supratentorial intraparenchymal tanycytic ependymoma.

Case Report

The patient is a 58-year-old male with a history of hypertension and type II diabetes mellitus who presented to an outside hospital after developing chin and right arm tremors, followed by a seizure. The seizure was complicated by a fall and urinary incontinence; the seizure resolved on its own. A CT completed at an outside hospital revealed a large, complex cystic mass in the frontal lobe and left hemispheric subarachnoid hemorrhage. The patient was administered levetiracetam and transferred to a specialty hospital for further evaluation. MRI analysis revealed a 5.6 × 8 × 5 cm complex cystic lesion in the left frontoparietal lobe, with a mass effect on the left lateral ventricle (fig. 1). This lesion included several nodular T2 bright and T1 isointense solid components. There was some enhancement in the cystic components that was also visualized on T1 imaging with gadolinium. Surgery was performed, and a left frontoparietal brain lesion, which was initially suspected to be a low-grade glioma, was removed. However, the tumor was surprising in its grayness and more firm than it would be expected for a low-grade glioma. The surgery was repeated 3 days later for microdissection and tissue harvesting. During his hospital stay, the patient developed waxing and waning expressive aphasia, with the development of global aphasia, a right facial droop, and right-sided weakness. A CT demonstrated hemorrhage in the resection cavity, effacement of the left superior frontoparietal sulci suggestive of cerebral edema, and a slight increase in left to right midline shift from 1.3 to 1.5 cm. This required surgery on postoperative day 6 for removal. However, it was unclear if the aphasia stemmed from the clot or cerebral edema following the surgery. On the day following evacuation of the hematoma, the patient's symptoms improved. The patient's symptoms included residual slurred speech, which improved over the subsequent month. At his last visit, 18 months following surgery, he continued to do well with no evidence of clinical or radiographic recurrence.
Fig. 1

Brain MRI with and without gadolinium images at diagnosis. a T1 without contrast. b T1 with contrast, c FLAIR.

Pathological analysis revealed brain tissue infiltrated by well-differentiated piloid cells with low-to-moderate cellularity (fig. 2). There was no microvascular proliferation or necrosis identified. Analysis of immunohistochemical staining revealed glial fibrillary acidic protein-positivity solely in reactive astrocytes. The proliferative index of the tumor was low, with only 2% of cells positive for Ki67 staining. Immunohistochemistry was also negative for mutant isocitrate dehydrogenase 1 (IDH1R132H). Immunohistochemistry against epithelial membrane antigen revealed a ‘dot-like’ positivity. A histological analysis revealed a tanycytic ependymoma (WHO Grade II).
Fig. 2

Pathology images staining patterns. a HE. ×20. b Glial fibrillary acidic protein. ×20. c HE. ×40. d Epithelial membrane antigen. ×40.

Discussion

This case report shows the diagnosis and current clinical outcome of a male adult patient with a supratentorial tanycytic ependymoma, WHO grade II. This rare variant of ependymoma commonly occurs in the spinal cord. In a review of the literature, we identified only 6 cases of ectopic supratentorial tanycytic ependymomas (table 1) [4, 5, 6, 7, 8, 9]. All patients were male, and their ages ranged from 2 to 59 years. Four cases were identified after the onset of seizures, one after the onset of headaches, and one was incidental. Locations varied among the cases, including both cortical and subcortical locations as well as right and left hemispheres. Tumors were frontal, temporoparietal, temporo-occipital, parietal, and parieto-occipital. In this series of patients, surgery was the primary treatment modality with no utilization of further radiotherapy or chemotherapy. The wide age ranges of the patients and the presence of the tumors throughout the hemispheres underscore the importance of considering ependymomas in the diagnosis of tumors occurring throughout the brain. This is especially crucial with regards to tanycytic ependymomas, which can be easily mistaken for pilocytic astrocytomas or fibroblastic meningiomas. This can occur due to the bipolar nature of the tumor cells on pathology along with low-to-moderate cellularity. Nonetheless, a number of nonconventional ependymoma variants can also mimic other tumors within the brain. Clear-cell ependymomas may appear histologically similar to oligodendrogliomas [10]. Papillary ependymomas may demonstrate features similar to those of choroid plexus tumors, while myxopapillary ependymomas may mimic chordomas [10]. In undiagnosed tumors that lack the typical staining pattern for more common intraparenchymal tumors, alternative diagnoses, including variants of ependymoma, must be considered.
Table 1

Cases of supratentorial tanycytic ependymomas

ReferenceSexAge, yearsLocationClinical presentationTreatment
Lopez et al. [current case]Male58Left frontoparietal lobeSeizuresSurgical resection
Reis et al. [7]Male06Right subcortical parieto-occipital lobeFocal seizures and headacheNot presented
Ito et al. [4]Male59Right temporo-occipital paratrigonalIncidentalSurgical resection
Richards et al. [8]Male16Left frontal lobeSeizuresSurgical resection
Rigante et al. [9]Male14Right temporoparietal lobeSeizuresSurgical resection
Kambe et al. [5]Male02Right superior parietal lobeAbsence seizuresSurgical resection
Langford et al. [6]Male13Left parietal lobeHeadachesNot presented
In conclusion, this case report represents the rare presentation of a tanycytic ependymoma in the supratentorial region in an adult male patient. Proper pathological diagnosis of the rare variant of ependymoma is warranted as it can impact prognosis and treatment.

Disclosure Statement

The authors have no competing interests to disclose.
  9 in total

1.  A case of tanycytic ependymoma arising from the cerebral hemisphere.

Authors:  Tamio Ito; Yoshimaru Ozaki; Hirohiko Nakamura; Shinya Tanaka; Kazuo Nagashima
Journal:  Brain Tumor Pathol       Date:  2006-10       Impact factor: 3.298

2.  Supratentorial tanycytic ependymoma: an uncommon fibrillary ependymoma variant.

Authors:  Fabiano Reis; Ricardo Schwingel; Francisco Carlos de Morais; Luciano de Souza Queiroz
Journal:  Arq Neuropsiquiatr       Date:  2011-08       Impact factor: 1.420

3.  A cortical cystic epileptogenic lesion: tanycytic ependymoma.

Authors:  Luigi Rigante; Mariangela Novello; Luca Massimi; Massimo Caldarelli
Journal:  Acta Neurol Belg       Date:  2012-11-16       Impact factor: 2.396

4.  Pediatric supratentorial cortical tanycytic ependymoma associated with absence seizures.

Authors:  Atsushi Kambe; Masamichi Kurosaki; Takashi Watanabe; Yoichi Nakazato
Journal:  Clin Neuropathol       Date:  2014 Jul-Aug       Impact factor: 1.368

Review 5.  Ependymomas in adults.

Authors:  Mark R Gilbert; Roberta Ruda; Riccardo Soffietti
Journal:  Curr Neurol Neurosci Rep       Date:  2010-05       Impact factor: 5.081

6.  Tanycytic ependymoma.

Authors:  L A Langford; G M Barré
Journal:  Ultrastruct Pathol       Date:  1997 Mar-Apr       Impact factor: 1.094

7.  Supratentorial tanycytic ependymoma.

Authors:  Amanda L Richards; Jeffrey V Rosenfeld; Michael F Gonzales; David Ashley; Catriona Mc Lean
Journal:  J Clin Neurosci       Date:  2004-11       Impact factor: 1.961

8.  The cytogenetic basis for classifying ependymomas.

Authors:  R L Friede; A Pollak
Journal:  J Neuropathol Exp Neurol       Date:  1978 Mar-Apr       Impact factor: 3.685

Review 9.  The 2007 WHO classification of tumours of the central nervous system.

Authors:  David N Louis; Hiroko Ohgaki; Otmar D Wiestler; Webster K Cavenee; Peter C Burger; Anne Jouvet; Bernd W Scheithauer; Paul Kleihues
Journal:  Acta Neuropathol       Date:  2007-07-06       Impact factor: 17.088

  9 in total
  1 in total

1.  The clinical features and surgical outcomes of intracranial tanycytic ependymomas: a single-institutional experience.

Authors:  Xiaogang Tao; Jinqian Dong; Zonggang Hou; Shuyu Hao; Qi Zhang; Zhen Wu; Junting Zhang; Baiyun Liu
Journal:  J Neurooncol       Date:  2017-06-26       Impact factor: 4.130

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.